Skip to main content
TSHA logo

Taysha Gene Therapies, Inc.

TSHANASDAQHealthcareBiotechnology

$4.01Today:- (-)1Y −18.93%

As of Oct 22, 2026 close

Market cap
$1.48B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.46$7.30
Volume (live)
-
Avg. volume (3M)
4.72M

Taysha Gene Therapies, Inc. (TSHA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Taysha Gene Therapies, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
(11 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$14.00
+249.56% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest TSHA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Kalpit Patel
Wolfe Research
BuyInitiates
-
Tazeen Ahmad
BofA Securities
BuyMaintains
-
Whitney Ijem
Canaccord Genuity
BuyMaintains
$17.00
Kristen Kluska
Cantor Fitzgerald
BuyMaintains
$19.00
Biren Amin
Piper Sandler
BuyMaintains
$12.00
Salveen Richter
Goldman Sachs
BuyMaintains
$13.00
Unknown Analyst
Wells Fargo
BuyReiterates
$11.00
Gil Blum
Needham
BuyMaintains
$12.00
Whitney Ijem
Canaccord Genuity
BuyMaintains
$17.00
Kristen Kluska
Cantor Fitzgerald
BuyMaintains
$19.00
Salveen Richter
Goldman Sachs
BuyMaintains
$13.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 17, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for TSHA?

The analyst consensus rating for TSHA is Buy, based on the latest ratings from 8 analysts over the last 90 days.

What is the average price target for TSHA?

The average 12-month price target for TSHA is $14.00, representing an upside of 249.6% from the Oct 22, 2026 close of $4.00.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.